An Ottawa woman’s death has intensified a conversation about whether provinces should be responsible for funding a costly hepatitis C medication.
Brenda Peever died on Nov. 4 after struggling with complications from hepatitis C. Now, her daughter, Jennifer, is speaking out about the family’s three-year fight to fund life-saving treatment.
Jennifer Peever says her family’s saga started when her mother contracted hepatitis C after receiving a tainted blood transfusion. Peever’s mother was later identified as a candidate for an effective -- but unaffordable -- drug.